APA način citiranja

Kato, J., Matsui, N., Kakehi, Y., Murayama, E., & Ohwada, S. (2020). Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial. Medicine (Baltimore).

Čikaški stil citiranja

Kato, Jitsu, Norimitsu Matsui, Yoshihiro Kakehi, Emiko Murayama, i Shoichi Ohwada. "Long-term Safety and Efficacy of Mirogabalin in Asian Patients With Postherpetic Neuralgia: Results From an Open-label Extension of a Multicenter Randomized, Double-blind, Placebo-controlled Trial." Medicine (Baltimore) 2020.

MLA način citiranja

Kato, Jitsu, et al. "Long-term Safety and Efficacy of Mirogabalin in Asian Patients With Postherpetic Neuralgia: Results From an Open-label Extension of a Multicenter Randomized, Double-blind, Placebo-controlled Trial." Medicine (Baltimore) 2020.